Bone Marrow TransplantationUmbilical CordBone MarrowTransplantation, HomologousBone Marrow CellsTransplantation, AutologousGraft vs Host DiseaseHematopoietic Stem Cell TransplantationFetal BloodWhole-Body IrradiationPeripheral Blood Stem Cell TransplantationTransplantation ConditioningHematopoietic Stem CellsCord Blood Stem Cell TransplantationBone and BonesAnemia, AplasticLeukemiaGraft SurvivalTransplantation ChimeraTissue DonorsBusulfanLiver TransplantationHistocompatibility TestingStem CellsBone Marrow PurgingCyclophosphamideHistocompatibilityUmbilical VeinsHematopoiesisHematologic NeoplasmsUmbilical ArteriesStem Cell TransplantationCombined Modality TherapyTransplantation, IsogeneicHematopoietic Stem Cell MobilizationBone Marrow DiseasesAntigens, CD34RecurrenceTime FactorsTreatment OutcomeGranulocyte Colony-Stimulating FactorMice, Inbred C57BLCells, CulturedKidney TransplantationLeukemia, Myeloid, AcuteT-LymphocytesLeukemia, Myelogenous, Chronic, BCR-ABL PositiveRemission InductionImmunosuppressive AgentsColony-Forming Units AssayRadiation ChimeraFlow CytometryLymphoma, Non-HodgkinPrecursor Cell Lymphoblastic Leukemia-LymphomaSpinal CordBone Marrow ExaminationCell DifferentiationBlood CellsGraft RejectionTransplantation ImmunologyAcute DiseaseHepatic Veno-Occlusive DiseaseLymphocyte DepletionLeukemia, MyeloidImmunosuppressionLeukocytes, MononuclearLeukocyte TransfusionLeukocyte CountHLA AntigensBone RemodelingRetrospective StudiesMelphalanAntineoplastic Combined Chemotherapy ProtocolsBone Marrow NeoplasmsSurvival AnalysisHematologic DiseasesGraft vs Host ReactionCell SeparationImmunophenotypingChimeraMyelodysplastic SyndromesLeukapheresisSevere Combined ImmunodeficiencyHeart TransplantationMultiple MyelomaAntigens, CDBlood Cell CountCyclosporineLymphocytesLymphocyte TransfusionFollow-Up StudiesSurvival RateEtoposideCytomegalovirus InfectionsCytarabineNuclear FamilyDisease-Free SurvivalGraft vs Leukemia EffectLung TransplantationPancytopenia